BrainsWay Ltd.
NASDAQ:BWAYMedical - Devices
+$0.05 today
- Market cap
- $352.22M
- Beta
- 0.15
- P/E (TTM)
- 61.7
- EPS (TTM)
- $0.23
Volume 0.15M
Average 0.15M
BWAY Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
BrainsWay Ltd.NASDAQ: BWAY
Net Margin · Q1 FY2026 · quarter ended Mar 2026
Net margin widens to 14.7%
Net margin was 14.7% in Q1 FY2026, up 5.1 pp from a year earlier. On a trailing-twelve-month basis it was 15.7%, up 6.7 pp year over year. Over 3 fiscal years it widened by 63.7 pp.
Context
- Net margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether net margin reaches the consensus estimate from 2 analysts of 8.9% for the fiscal year ending Dec 2026, down from 14.6% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 14.7%-5.4 pp QoQ
- Last fiscal yearDec 2025
- 14.6%+7.5 pp YoY
- LTMMar 2026
- 15.7%+6.7 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +5.1 pp | -6.2 pp | -11.3 pp |
| 1 year | +7.5 pp | -5.7 pp | -13.2 pp |
| 3 years | +63.7 pp | -3.6 pp | -67.4 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 14.6%
- Year-over-year change
- +7.5pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 14.6% | +7.5pp |
| FY2024 | 2024-12-31 | 7.1% | +20.3pp |
| FY2023 | 2023-12-31 | -13.2% | +35.9pp |
| FY2022 | 2022-12-31 | -49.1% | -27.3pp |
| FY2021 | 2021-12-31 | -21.8% | — |
Net Margin vs competitors
How BWAY compares with its peers on the latest reported figures
- BWAY's LTM Mar 2026 net margin of 15.7% is the highest of the 4 companies compared; the peer median is -24.5%.
- Its year-over-year change of +6.7 pp is the lowest of 4, against a peer median of +29.8 pp.
- Over three fiscal years its change of +63.7 pp compares with a peer median of +82.0 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 15.7% | +6.7 pp | +63.7 pp | |
| LTM Mar 2026 | -21.7% | +7.8 pp | +82.0 pp | |
| LTM Mar 2026 | -24.5% | +29.8 pp | +30.8 pp | |
| LTM Mar 2026 | -1427.1% | +1583.0 pp | +1108.5 pp | |
MOBIMobia Medical, Inc. Common Stock | — | — | — | — |
| Peer median (excluding BWAY) | -24.5% | +29.8 pp | +82.0 pp | |
Competitors are the stored peer set for BWAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 29.66M | 27.18M | 31.79M | 41.02M | 52.23M |
| Cost of Revenue | 6.6M | 7.13M | 8.31M | 10.44M | 12.84M |
| Gross Profit | 23.06M | 20.05M | 23.48M | 30.58M | 39.39M |
| Gross Margin | 77.7% | 73.8% | 73.9% | 74.6% | 75.4% |
| Research & Development | 6.39M | 7.68M | 6.67M | 7.19M | 9.6M |
| Selling, General & Admin | 21.66M | 25.05M | 21.64M | 22M | 25.46M |
| Operating Expenses | 28.06M | 32.73M | 28.44M | 29.19M | 35.06M |
| Depreciation & Amortization | 1.69M | 1.53M | 1.34M | 1.77M | 1.54M |
| EBITDA | (4.67M) | (11.45M) | (2.56M) | 5.36M | 11.46M |
| EBITDA Margin | -15.8% | -42.1% | -8.1% | 13.1% | 21.9% |
| Operating Income | (5M) | (12.68M) | (4.96M) | 1.39M | 4.32M |
| Operating Margin | -16.9% | -46.7% | -15.6% | 3.4% | 8.3% |
| Interest Income | 225K | 1.11M | 2.17M | 2.48M | 5.64M |
| Interest Expense | 141K | 68K | 298K | 1.36M | 2.23M |
| Other Income / Expenses | (1.42M) | (351K) | 1.01M | 2.07M | 3.39M |
| Income Before Tax | (6.42M) | (13.03M) | (3.95M) | 3.46M | 7.71M |
| Pre-Tax Margin | -21.6% | -48.0% | -12.4% | 8.4% | 14.8% |
| Income Tax Expense | 43K | 315K | 251K | 538K | 77K |
| Net Income | (6.46M) | (13.35M) | (4.2M) | 2.92M | 7.63M |
| Net Margin | -21.8% | -49.1% | -13.2% | 7.1% | 14.6% |
| EPS (Basic) | (0.21) | (0.43) | (0.13) | 0.09 | 0.40 |
| EPS (Diluted) | (0.21) | (0.43) | (0.13) | 0.09 | 0.36 |
| Weighted Avg Shares | 31.15M | 32.98M | 33.16M | 33.97M | 19.08M |
| Weighted Avg Shares (Diluted) | 31.15M | 32.98M | 33.16M | 34.77M | 21.21M |
BrainsWay Ltd.
NASDAQ:BWAY
Intrinsic Alpha fair value
Locked
Current Price
$8.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.